TransMedics Leases Assembly Innovation Park Lab Tower
An Andover-based organ transplant company leased a vacant lab tower in Somerville and acquired adjacent properties for $30 million.
An Andover-based organ transplant company leased a vacant lab tower in Somerville and acquired adjacent properties for $30 million.
Somerville City Councilors approved a 10-year tax break designed to lure an Andover medtech company to BioMed Realty’s Assembly Innovation Park.
West Cambridge’s lab submarket got a boost from an AI-focused startup’s 235,000 square-foot lease at 1 and 5 Alewife Park.
A Cambridge biotech will relocate to Watertown after terminating its lease and committing to occupy nearly 73,000 square feet at 99 Coolidge Ave.
A developer that specializes in office to lab conversions secured the largest life science lease of 2025 in Boston with a four-year-old company founded by Harvard University researchers.
The lab space vacancy rate hit 25 percent across the region during the first quarter, as companies continued to downsize and list new sublease space.
The first life science tenant at Harvard’s new Allston development is a research center that could eventually become home to 500 employees.
A speculative life science development completed in June landed its first two leases committing to more than half of the 225,000-square-foot building outside Watertown Square.
Lab leasing in Greater Boston declined to the lowest level since the pandemic as life science companies shied away from real estate commitments in a frugal funding climate.
As more life science conversions and new developments were completed without tenants, Greater Boston’s lab vacancy rate rose to 13.7 percent in the first quarter.
Dana-Farber Cancer Institute will expand its lab and research space in Boston’s Longwood Medical Area and the Fenway while its office space shrinks under a permanent remote and hybrid workforce model.
Greater Boston’s largest lab landlord said vacancies in its local portfolio topped 7 percent in the fourth quarter, but a revival in life science industry expansion plans points to growth in 2024.
Greater Boston’s life science cluster remains an island of stability in the commercial real estate world while other property sectors reel from COVID-19 disruption.